Lastly, metformin, a medication typically prescribed for type 2 diabetes, may provide adjunctive benefits in endometriosis treatment by addressing insulin resistance and inflammation, as well as modulating pathways like mTOR and reducing the expression of vascular endothelial growth factor (VEGF), which plays a key role in lesion angiogenesis [47]. This evidence concerns the gene VEGFA and endometriosis.